FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - Immunization, Realm US

19,481 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 14800 - 15000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7447Nationally Notifiable Event Code (Generic)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7276Nationally Notifiable Event Code (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1015Nationally Notifiable Disease Surveillance System (NNDSS) & Other Conditions of Public Health Importanceactive2021-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1016Nationally Notifiable Infectious Disease reportable to the Nationally Notifiable Disease Surveillance Systemactive2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3589Observation Identifier (Syndromic Surveillance)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3000PHLIP Questions (Flu)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3245Radiology Lab Test (Flu)active2009-01
hl7.fhir.us.davinci-crdR4ValueSet/DocReasonCRD Coverage Information Documentation Reason Value Settrial-use1fm2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.834Allergenactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3246Specimen (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7488Specimen Type (Arbovirus)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7653Specimen Type (CRS)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7841Specimen Type (Lyme)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7657Specimen Type (Rubella)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7463Specimen Type (Zika)active2016-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7885Public Site of Exposure (CO)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7896Residential Site of Exposure (CO)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7784Diet Type (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7995Diet Type (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3270Therapy 7 Days Prior or After Illness Onset (Pediatric Flu)active2009-01
rapportendoscopiequebec.testR4ValueSet/ca-qc-endo-valueset-villeendoVilleEndoactive2024-05hl7
rapportendoscopiequebec.testR4ValueSet/ca-qc-endo-valueset-voieadministrationendoVoieAdministrationEndoactive2024-05hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7801Signs and Symptoms (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7817Type of Dairy Product (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7782Deli Meats (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7783Deli Salads (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7789Fruit (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7792Illness (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7786Food (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7796Patient Type (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7785Extended Race Group (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7805Yes No None (Listeria)active2018-01
hl7.fhir.us.registry-protocolsR4ValueSet/AntiarrhythmicsAll Antiarrhythmicsactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3308Complications (Malaria)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3268Acute Illness Complications (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3269Underlying Conditions (Pediatric Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3311Medication Prophylaxis (Malaria)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3312Medication Treatment (Malaria)active2019-01
hl7.fhir.us.pq-cmc-fdaR5ValueSet/cmc-specification-types-vsSpecification Section Type Terminologytrial-use2brr2025-07hl7
ca.on.dhdr.r4.v4R4ValueSet/accdr-vs-location-physical-typeLocation Physical Typeactivehl7
hl7.fhir.us.registry-protocolsR4ValueSet/LocationInGraftLocation in the CABG Graftactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8009Exposure Location (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7988Location Type (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7797Birth Location (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1052Transmission Setting (NND)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3201Geographical location historyactive2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3209Exposure Locationactive2009-01
hl7.fhir.us.registry-protocolsR4ValueSet/ValvularStenosisValvular Stenosisactivecic2023-11hl7
hl7.fhir.us.breast-radiologyR4ValueSet/LymphNodeAbnormalityTypeVSLymph Node Type ValueSetactive2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1007Major Site of Disease (TB)active2008-01
hl7.fhir.us.registry-protocolsR4ValueSet/CABGTypeCoronary Artery Bypass Graft Typeactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/StentTypeCathPCI List of Stent Typesactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3152Whole Cell ELISA Manufacturer (VZ)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3153gp ELISA Manufacturer (VZ)active2008-01
fhir.mamaTotoR4ValueSet/maritalStatusVSMarital Statusdraft2025-06hl7
fhir.r4.wales.testR4ValueSet/DataStandardsWales-MaritalStatusData Standards Wales Marital Statusactive2023-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.1.11.12212Marital Status Value Setactive2009-01
signal.core.r4R4ValueSet/questionnaire-ccars-marital-statusQuestionnaire CCARS Marital Statusdraft1pahl7
hl7.fhir.us.splR5ValueSet/valueset-splMarketingStatusesSPL Marketing Statuses ValueSettrial-use1brr2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7848Exposure Setting Master (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7845Serotype Master (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7846Lab Test Interpretation Master (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7847Lab Test Type Master (RIBD)active2018-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1138.564CABG or PCI Procedureactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1138.565CABG or PCI Procedureactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1138.566CABG or PCI Procedureactive2018-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.120.11.1007HIV 1active2024-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3126Genotype (Measles)active2008-01
hl7.fhir.us.davinci-vbprR4ValueSet/vbp-measure-populationVBP Measure Population Typetrial-use1cqi2025-07hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7669Food Processing Method (Trich)active2018-01
hl7.fhir.us.registry-protocolsR4ValueSet/MechanicalVentricularSupportTimingMechanical Ventricular Support Timingactivecic2023-11hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/MedDRATransfusionAdverseEventVSTransfusion-related Adverse Eventsdraft2023-08hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/MedDRAVaccinationAdverseEventVSVaccination-related Adverse Eventsdraft2023-08hl7
signal.core.r4R4ValueSet/questionnaire-ccars-rae-aso-identification-codesQuestionnaire CCARS RAE ASO Identification Codesdraft1pahl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7636Medical History (FDD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7795Medical History (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.916Medical Specialty (HL7)active2008-01
hl7.fhir.us.pacio-adiR4ValueSet/ADIDMedicallyAssistedHydrationNutritionOrderGroupingVSMedically Assisted Hydration Order Groupingtrial-use2pe2025-08hl7
hl7.fhir.us.pacio-adiR4ValueSet/ADIDMedicallyAssistedHydrationNutritionOrderVSMedically Assisted Hydration Ordertrial-use2pe2025-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7932Duration Units (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7931Medication Frequency Unit (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7635Medication Administered (FDD)active2017-01
fhir.cdc.opioid-cds-r4R4ValueSet/methadone-medicationsMethadone medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8024Medication Completed (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7972Medication (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7839Medication Received (Lyme)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3147Medication Received (VZ)active2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.183Findings Related to Medication Management, Medication relatedactive2021-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7929Medication Route (STD)active2020-01
fhir.cdc.opioid-cds-r4R4ValueSet/cns-depressant-medicationsCNS depressant medicationsactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/non-synthetic-opioid-medicationsNon-synthetic opioid medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7710Medication Pre-Treatment (RIBD)active2018-01
signal.core.r4R4ValueSet/questionnaire-ccars-history-of-mental-health-servicesQuestionnaire CCARS History Of Mental Health Servicesdraft1pahl7
hl7.fhir.us.dme-ordersR4ValueSet/PAOx-Message-EventPAO Message Eventdraft2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.15MetabolicSyndromeConditionactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.9Metabolic Syndrome ICD10active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.12Metabolic Syndrome LOINCactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.33Metastatic Breast Canceractive2023-09hl7
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-radiotherapy-respiratory-motion-management-vsRadiotherapy Respiratory Motion Management Value Setactivecgp2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7698Gestational Age Determination (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7199Detection Method (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7696Detection Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7671Food Cooking Method (Trich)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3083Food Cooking Method (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7930Route of Administration (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3084Food Processing Method (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7727Titer Test Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3142Test Method EIA IgMactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7105VPD Specimen Collection Methodactive2020-01
hl7.cda.us.eyecareR5ValueSet/RefractionMethodCodesRefraction Method Codesdraft2024-02hl7
hl7.cda.us.eyecareR5ValueSet/VisualAcuityMethodCodesVisual Acuity Method Codesdraft2024-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3257Surveillance Method (Novel Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1009Microorganismactive2019-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7200Lab Results (STD)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.49MSI Testingactive2023-11hl7
hl7.fhir.us.military-serviceR4ValueSet/military-service-branch-vsMilitary Branch Value Setactive2023-05hl7
hl7.fhir.us.military-serviceR4ValueSet/military-service-military-occupation-vsMilitary Occupation Value Setactive2023-05hl7
hl7.fhir.us.directory-queryR4ValueSet/MinEndpointConnectionTypeVSMinimum Endpoint Connection Types Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/MinEndpointConnectionTypeVSMinimum Endpoint Connection Types VStrial-usefm2025-02hl7
hl7.fhir.us.codex-radiation-therapyR4ValueSet/codexrt-image-guided-radiotherapy-modality-vsImage Guided Radiotherapy Modality Value Setactivecgp2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7684Mode of Delivery (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3107Travel Modeactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7765Molecular Indel (TB)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7766Molecular Test Methods (TB)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7764Molecular Test Results (TB)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7165Previous Cesarean (NCHS)active2014-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7218Syphilis Clinical Stage (CS)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8046Mother Nucleic Acid Test Result (Perinatal Hep)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7222Serologic Response (CS)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7219Syphilis Surveillance Stage (CS)active2019-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7768Moved Where During Therapy (TB)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7808N. meningitidis Serogroup (RIBD)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.112Chronic kidney disease I10active2023-09hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.3.520.4.16NAACCR ICD-9-CM Cancer Reportability Listactive2012-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.28Her2 Negativeactive2023-09hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6006Legacy Reporting Jurisdiction (CDS)active2011-01
fhir.org.nz.ig.baseR4ValueSet/nhi-useValid use values for NHIactive2025-06hl7
fhir.r4.nhsengland.programmeR4ValueSet/England-ObservationCodeEngland Observation Codedraft2024-12hl7
fhir.r4.nhsengland.programmeR4ValueSet/England-ObservationValueCodeEngland Observation Value Codedraft2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.89Maternal Diagnosesactive2023-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.113883.13.19Healthcare Service Location (NHSN)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3380Substance Refusal Reason (IIS)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3381Observation Identifier (IIS)active2010-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.55Risk assessments relevant to pain managementactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.180Outpatient Prenatal Visitactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.182Eclampsiaactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.184Preexisting Hypertension in Pregnancyactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.185Postpartum Encounteractive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.186Postpartum Encounteractive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.187Postpartum Encounteractive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.189Spontaneous or Elective Abortionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.190Spontaneous or Elective Abortionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.191Preeclampsia or Eclampsiaactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.193Spontaneous or Elective Abortionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.179Hypertensive disorders in pregnancyactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.192Spontaneous or Elective Abortion Procedureactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.183Gestational Hypertensionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1108.188Preexisting Hypertension in Pregnancyactive2024-10hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFEItemRevenueVSPCT GFE NUBC Revenue Value Settrial-usefm2025-08hl7
hl7.fhir.us.davinci-pctR4ValueSet/PCTGFETypeOfBillVSPCT GFE NUBC Uniform Billing (UB-04) Type of Bill Value Settrial-usefm2025-08hl7
signal.core.r4R4ValueSet/provider-taxonomyProvider Taxonomy Codesdraftvocab2023-03hl7
fhir.cdc.opioid-cds-r4R4ValueSet/oncology-specialty-designationsOncology specialty designations (NUCC)active2023-05hl7
hl7.fhir.us.vdorR4ValueSet/vdor-gun-owner-codes-vsVDOR Coding Manual Gun Owner Codes Value Setinformativepher2025-06hl7
hl7.fhir.us.registry-protocolsR4ValueSet/NewYorkHeartAssociationAnswersNew York Heart Association OA Answer Listactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1021.121Federal Administrative Sexactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3043Lab Test Result Name (Hepatitis)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7954Medication Administered (Hansen)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7963Medication Administered (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7721Cruise Line (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7958Hospital Procedure (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7952Tribe Name (NND)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.292Non pharmacologic treatments for chronic pain NCIactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3279H1N1 Vaccine Manufactureractive2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3236National Reporting Jurisdictionactive2009-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.581PIM_Avandametactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.26Nonopioid pain medicationsactive2023-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.59DIRSectionTypeCodesactive2024-06hl7
fhir.org.nz.ig.baseR4ValueSet/coverage-typeCoverage Typeactive2025-06hl7
fhir.org.nz.ig.baseR4ValueSet/coverage-categoryCoverage Categoryactive2025-06hl7
fhir.org.nz.ig.baseR4ValueSet/iwiIwiactive2025-06hl7
fhir.giisR4ValueSet/NonVaccinationReasonVSNon vaccination reasondraft2025-07hl7
hl7.fhir.us.hsdsR4ValueSet/NonIndividualSpecialtiesNon-Individual Specialtiestrial-use2hss2023-10hl7
hl7.fhir.us.directory-queryR4ValueSet/NonIndividualSpecialtiesVSNon-Individual Specialtiesactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/NonIndividualSpecialtiesVSNon-Individual Specialtiestrial-usefm2025-02hl7
hl7.fhir.us.directory-queryR4ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates Value Setactive2022-12hl7
hl7.fhir.us.davinci-pdex-plan-netR4ValueSet/NonIndividualSpecialtyAndDegreeLicenseCertificateVSNon-Individual Specialties, Degrees, Licenses, and Certificates VStrial-usefm2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1046.279Triageactive2025-02hl7
hl7.fhir.us.registry-protocolsR4ValueSet/NonSustainedVentricularTachycardiaTypeNon-Sustained Ventricular Tachycardia Typeactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7279Non-Treponemal Test Result (STD)active2017-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1213.114NSAIDs Ingredients and Risk of GI Bleedingactive2023-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7142Non-Vertex Presentation (NCHS)active2014-01
hl7.fhir.us.mcodeR4ValueSet/mcode-normalization-basis-vsNormalization Basis Value Setactivecic2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.208Social Determinants of Health Screening Assessments Answersactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.207Social Determinants of Health Screening Assessments Questionsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.206Social Determinants of Health Screening Assessments And Questionsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.126Social Determinants of Health Screening Assessmentsactive2023-12hl7
hl7.fhir.us.breast-radiologyR4ValueSet/NotPreviouslySeenVSNotPreviouslySeen ValueSetactive2022-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.815Drugs of Abuse Screen in Urineactive2023-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1222.898Forearm X Rayactive2024-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.455Metabolic acidosis I10active2023-07hl7